Apoptotic depletion of CD4+ T cells in idiopathic CD4+ T lymphocytopenia

Journal of Clinical Investigation

Volumn 97, Issue 3, 1996, Pages 672-680

  Laurence, Jeffrey ^a   Mitra, Debashis ^a   Steiner, Melissa ^a   Lynch, David H ^b   Siegal, Frederick P ^c   Staiano Coico, Lisa ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b AMGEN INC   (United States)

^c LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

aurintricarboxylic acid; cell death, programmed; immunologic deficiency syndromes; T lymphocyte

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; DNA CLEAVAGE; FEMALE; HUMAN; IMMUNOPATHOGENESIS; LYMPHOCYTE DEPLETION; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTOPENIA; MALE; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PROTEIN CROSS LINKING; T LYMPHOCYTE;

EID: 0030062181     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118464     Document Type: Article

References (51)

1. Laurence, J., F.P. Siegal, E. Schattner, I.H. Gelman, and S Morse. 1992. Acquired immunodeficiency without evidence of infection with human immuno-deficiency virus types 1 and 2 Lancet. 340:273-274.
2. Spira, T.J., B.M. Jones, J.K.A. Nicholson, R.B. Lal, T. Rowe, A.C. Mawle, C.B. Lauter, J.A. Shulman, and R.A. Monoon. 1993. Idiopathic CD4+ T-lymphocytopenia, an analysis of five patients with unexplained opportunistic infections. N. Engl. J. Med. 328:385-392.
3. Duncan, R A., C.F von Reyn, G M. Alliegro, Z Toossi, A.M Sugar, and S.M. Levitz 1993. Idiopathic CD4+ T lymphocytopenia: four patients with opportunistic infections and no evidence of HIV infection. N. Engl. J. Med. 328: 393-398.
4. World Health Organization 1992. Unexplained severe immunosuppression without evidence of HIV infection. WHO Wkly. Epidem. Rec 42:309-311.
5. Laurence, J. 1993. T-cell subsets in health, infectious disease, and idiopathic CD4+ T lymphocytopenia. Ann. Intern. Med. 119:55-62.
6. Laurence, J 1993. CD4+ T-lymphocytopenia without HIV infection. N. Engl J. Med 328:1848-1849.
7. Razvi, E S., and R.M. Welsh. 1993. Programmed cell death of T-lymphocytes during acute viral infection: a mechanism for virus-induced immune deficiency. J Virol. 67:5754-5765.
8. Gonzalo, J.A., A. Gonzalez-Garcia, T. Kalland, G. Hedlund, A.C. Martinez, and G. Kroewer. 1994. Linomide inhibits programmed cell death of peripheral T cells in vivo. Eur. J. Immunol. 24:48-52.
9. Uehara, T., T. Miyawaki, K. Ohta, Y. Tamaru, T. Yokoi, S. Nakamura, and N Taniguchi. 1992 Apoptotic cell death of primed CD45RO+ T lymphocytes in Epstein-Barr virus-induced mononucleosis Blood. 80:452-458.
10. Pandolfi, F., M. Pierdominici, A. Oliva, G. D'Offizi, I Mezzaroma, B. Mollicone, A. Giovannetti, L. Ramaldi, I. Quinti, and F. Aiuti 1995. Apoptosis-related mortality in vitro of mononuclear cells from patients with HIV infection correlates with disease severity and progression. J. Acquired Immune Defic. Syndr 9:450-458.
11. Finkel, T.H., G. Tudor-Williams, N.K. Banda, M F. Cotton, T. Curiel, C Monks, T W. Baba, R.M. Ruprecht, and A. Kupper. 1995. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV-and SIV infected lymph nodes Nature Med 1 129-134.
12. Laurent-Crawford, A G., B. Krust, S. Muller, Y. Riviere, M.-A. Rey-Cuille, J.-M. Bechet, L. Montagnier, and A.G. Hovanessian. 1991. The cytopathic effect of HIV is associated with apoptosis. Virology. 185:829-839.
13. Alderson, MR., T.W. Tough, S. Braddy, T. Davis-Smith, E. Roux, K. Schooley, R.E. Miller, and D.H. Lynch 1994. Regulation of apoptosis and T cell activation by Fas-specific mAb. Int Immunol 6:1799-1806.
14. Laurence, J., A.S. Hodtsev, and DN. Posnett. 1992. Super-antigen implicated in dependence of HIV-1 replication in T cells on TCR Vβ expression. Nature (Lond.) 358:255-259.
15. Bofill, M., G. Janossy, C A. Lee, D. Macdonald-Burns, A.N. Phillips, C. Sabin, A. Timms, M.A. Johnson, and P.B.A Kernoff. 1992. Laboratory control values for CD4 and CD8 T lymphocytes Implications for HIV-1 diagnosis. Clin Exp. Immunol. 88:243-252
16. Laurence, J., H. Cooke, and S.K Sikder. 1990 Effect of tamoxifen on regulation of viral replication and human immunodeficiency virus (HIV) long terminal repeat-directed transcription in cells chronically infected with HIV-1. Blood 75:696-703.
17. Darzynkiewicz, Z., S. Bruno, G. DelBino, W Gorczyca, A. Hotzma, P Lassota, and F. Traganos. 1992. Features of apoptotic cells measured by flow cytometry. Cytometry 13 795-808
18. Oyaizu, N., T.W. McCloskey, M. Coronesi, N Chirmule, V S. Kalyanaraman, and S. Pahwa. 1993 Accelerated apoptosis in peripheral blood mononuclear cells (PBMCs) from human immunodeficiency virus type 1 infected patients and in CD4 cross-linked PBMCs from normal individuals. Blood. 82: 3392-3400.
19. Terai, C., R.S. Kornbluth, C D. Pauza, D.D. Richman, and D.A. Carson. 1991. Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1. J Clin. Invest. 87:1710-1715
20. McConkey, D J., P. Hartrell, P. Nicotera, and S Orrenius 1989. Calcium-activated DNA fragmentation kills immature thymocytes. FASEB J. 3:1843-1849.
21. Itoh, N., S. Yonehara, A. Ishii, M. Yonehara, S.-I. Mizushima, M. Sameshima, A. Hare, Y Seto, and S. Nagata. 1991. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66: 233-243.
22. Takahashi, T., M. Tanaka, J. Inazawa, T. Abe, T Suda, and S. Nagata. 1994 Human Fas-ligand: gene structure, chromosomal location and species specificity. Int Immunol. 6:1567-1574
23. Iwai, K., T. Miyawaki, T. Takizawa, A Konno, K Ohta, A Yachie, H. Seki, and N. Taniguchi. 1994. Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils. Blood 84 1201-1208.
24. Alderson, M.R., T W. Tough, T. Davis-Smith, S. Braddy, B. Falk, K.A Schooley, R.G. Goodwin, C.A. Smith, F. Ramsdell, and D.H. Lynch. 1995. Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181:71-77.
25. Debatin, K.M , A. Fahrig-Faissuer, S. Enekel-Stodt, W. Krenz, A. Brenner, and P.H. Krammer. 1994. High expression of APO-1 (CD95) on T Lymphocytes from human immunodeficiency virus-1 infected children. Blood. 83:3101-3103
26. Brunner, T., R.J. Mogil, D. LaFace, N.J. Yoo, A. Mahboubi, F. Echeverri, S.J. Martin, W.R. Force, D.H Lynch, C.F. Ware, and D.R. Green. 1995. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature (Lond.). 373:441-444.
27. Ramsdell, F., M.S. Seaman, R E. Miller, T.W. Tough, M.L. Alderson, and D.H. Lynch. 1994. gld/gld mice are unable to repress a functional ligand for Fas. Eur. J. Immunol. 24:928-936.
28. Wyllie, A.M., J.F R Kerr, and A.R. Currie. 1980. Cell death: the significance of apoptosis. Int. Rev Cytol. 68:251-306.
29. Cushman, M., and P. Sherman. 1990. Inhibition of HIV-1 integration protein by aurintricarboxylic acid monomers, monomer analogs, and polymer fractions Biochem. Biophys. Res. Commun. 172:1298-1301.
30. 2+ concentration and DNA fragmentation. Cancer Res. 52:1342-1346.
31. Rowlands, M.G , I.B. Parr, R. McCagne, M. Jarman, and P.M Goddard. 1990. Variation of the inhibition of calmodulin dependent cyclic AMP phosphodiesterase amongst analogues of tamoxifen: correlations with cytotoxicity. Biochem. Pharmacol. 40:283-289.
32. 2+ concentration. Arch. Biochem. Biophys. 269:365-370.
33. Hermeking, H., and E. Eick. 1994. Mediation of c-myc-induced apoptosis by p53. Science (Wash. DC). 265:2091-2093.
34. Gougeon, M.-L., S. Garcia, J. Heeney, R. Tschopp, H Lecoeur, D. Guetard, V. Rame, C. Dauguet, and L Montagnier. 1993. Programmed cell death in AIDS-related HIV and SIV infections. AIDS Res. Hum. Retroviruses 9:553-563.
35. Bryson, G J., B.V. Harmon, and R J. Collins 1994 A flow cytometeric study of cell death: failure of some models to correlate with morphological assessment. Immun Cell Biol. 72:35-41.
36. Muller, S., P Richalet, A. Laurent-Crawford, S. Barakat, Y. Riviere, F. Porrot, S. Chamaret, J.-P. Briand, L. Montagnier, and A. Hovanessian. 1992. Presence in HIV seropositive patients of autoantibodies typically found in non-organ specific autoimmune diseases. AIDS. 6:933-940.
37. Fultz, P.N., R.B. Stricker, H.M. McClure, D.C Anderson, W M. Switzer, and C. Horaist. 1990. Humoral response to SIV/SMM infections in macaque and mangabey monkeys J. Acquired Immune Defic. Syndr. 3:319-329.
38. Miyawaki, T., T. Uehara, R. Nibu, T. Tsuji, A. Yachie, S. Yoneham, and N. Taniguchi. 1992. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J Immunol. 149:3753-3760.
39. Alderson, M.R., R.J. Armitage, E. Maraskovsky, T.W. Toough, E. Roux, K. Schooley, F. Ramadell, and D.H. Lynch. 1993. Fas transduces activation signals in normal human T lymphocytes. J. Exp Med. 178:2231-2235.
40. Mitra, D., M. Steiner, D.H. Lynch, L. Staiano-Coico, and J. Laurence. 1996. HIV-1 upregulates Fas ligand expression in CD4 + T cells in vitro and in vivo: association with Fas-mediated apoptosis and modulation by aurintricarboxylic acid. Immunology. In press.
41. Kobayashi, N., Y. Hamamoto, N. Yamamoto, A. Ishii, M. Yonchora, and S. Yonchara. 1990. Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication. Proc. Natl. Acad. Sci. USA. 87:9620-9624.
42. Cheng, J., T. Zhou, C. Liu, J.P Shapiro, M.J. Brauer, M.C. Kiefer, P J. Barr, and J.D. Mountz. 1994. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science (Wash. DC). 263:1759-1762.
43. Laurence, J. 1994. CD4+ lymphocytopenia in systemic lupus erythematosus. Ann Intern Med. 120 168-169
44. Emlen, W., J A. Niebur, and R. Kadera. 1994. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol. 152:3685-3692.
45. Groux, H., G. Torpier, D. Monte, Y. Mouton, A. Capron, and J C. Ameisen. 1992. Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals. J. Exp Med 175:331-340.
46. Jacobson, M.D., J.F. Burne, and M.C. Raff. 1994 Programmed cell death and Bcl-2 protection in the absence of a nucleus. EMBO J. 13:1899-1910
47. Yang, Y., M Mercep, C.F. Ware, and J D. Ashwell. 1995. Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by retinoic acid and glucocorticoids J. Exp. Med. 181: 1673-1682.
48. Neito, M.A., and A. Lopez-Rivas. 1989. IL-2 protects T lymphocytes from glucocorticoid-induced DNA fragmentation and cell death. J. Immunol 143:4166-4170.
49. Clerici, M., A. Sarin, R.L. Coffman, T A. Wynn, S.P. Blatt, C.W. Hendrix, S.F. Wolf, G.M. Shearer, and P.A. Henkart. 1994 Type 1/type 2 cytokine modulations of T cell programmed cell death as a model for human immunodeficiency virus pathogenesis Proc. Natl. Acad. Sci. USA 91:11811-11815.
50. + T-lymphocytopenia Transfusion (Bethesda). 34:192-197.
51. Rezza, G., P. Pezzotti, and F. Aiuti. 1995. Acquired immunodeficiency without HIV infection: epidemiology and clinical outcome in Italy. BMJ (Br. Med. J.). 311:785-786.